Global Market Bulletin
  • Home
  • Stock Market News
  • Investing
  • Economy
  • CEO Interviews
  • Contact Us
No Result
View All Result
SUBSCRIBE
Global Market Bulletin
  • Home
  • Stock Market News
  • Investing
  • Economy
  • CEO Interviews
  • Contact Us
No Result
View All Result
Global Market Bulletin
No Result
View All Result
Home Stock Market News

5 Stocks With Billion-Dollar Potential You Should Not Miss

by Global Market Bulletin
July 25, 2026
in Stock Market News
0
5 Stocks With Billion-Dollar Potential You Should Not Miss

5 Stocks With Billion-Dollar Potential You Should Not Miss

16
SHARES
34
VIEWS
Share on FacebookShare on Twitter

1. Oracle Corporation (NYSE:ORCL)

Oracle Corporation (NYSE: ORCL) earns the No. 1 position after securing a 10-year enterprise software agreement with the Pentagon worth up to nearly $7 billion. The contract consolidates existing U.S. military Oracle software arrangements into a single enterprise agreement and is expected to reduce duplication, improve visibility over software usage and save taxpayers at least $441 million over the life of the agreement. of the agreement is important, but its duration may be even more valuable. A 10-year government contract can provide unusually visible and dependable revenue. It also deepens Oracle Corporation (NYSE: ORCL)’s relationship with one of the world’s largest and most security-conscious organizations. Winning a direct enterprise agreement of this scale demonstrates that Oracle Corporation (NYSE: ORCL)’s databases, enterprise applications and infrastructure remain deeply embedded in mission-critical government systems.

You might also like

10 Stocks With Billion-Dollar Potential You Should Not Miss

Could ARS Pharmaceuticals (SPRY) Disrupt the Emergency Allergy Treatment Market?

Is Lexeo Therapeutics (LXEO) a Good Gene Therapy Stock for Long-Term Growth?

This matters because investors have become increasingly concerned about how artificial intelligence could disrupt traditional software companies. Some software stocks have suffered as markets question whether AI agents will replace existing applications, compress subscription prices or weaken long-established business models. The Pentagon agreement is a reminder that large organizations cannot simply abandon mission-critical databases and enterprise systems overnight. Migration is expensive, operationally difficult and potentially risky.

Oracle Corporation (NYSE: ORCL) is also building a larger presence in cloud infrastructure and AI computing. Its combination of database software, cloud services and enterprise applications allows the company to sell both the underlying infrastructure and the software used to manage information. Government agencies, healthcare organizations, banks and multinational corporations often value reliability and security more than the lowest possible price, giving Oracle Corporation (NYSE: ORCL) an opportunity to defend premium relationships.

The stock had experienced a severe decline before the contract announcement, which improves the potential risk-reward setup compared with companies trading near euphoric valuations. A beaten-down share price combined with a multi-billion-dollar contract can create a stronger catalyst than good news announced by a stock that already reflects near-perfect expectations.

The contract will not automatically solve every challenge. Revenue will be recognized over many years rather than immediately, and Oracle Corporation (NYSE: ORCL) still faces intense competition from major cloud providers, database alternatives and emerging AI-native software platforms. Investors must also determine whether capital spending on cloud capacity will produce adequate returns.

Even with those risks, Oracle Corporation (NYSE: ORCL) has the strongest combination of contract visibility, strategic validation, recurring revenue potential and valuation recovery opportunity among the companies considered. The Pentagon agreement provides a concrete financial catalyst at a time when many technology businesses are asking investors to trust distant promises. Oracle Corporation (NYSE: ORCL) has secured an actual customer commitment that could last an entire decade.

YOU MUST READ THIS: 10 Stocks Under $10 Analysts Believe Could Soar 200%

Disclosure: No material interests to disclose. This article was originally published on Global Market Bulletin.

Page 5 of 5
Prev1...45
Tags: 5 Stocks With Billion-Dollar Potential You Should Not MissAmkor Technology Inc. (NASDAQ:AMKR)Daily NewsletterDell Technologies Inc. (NYSE:DELL)HeadlineIntel Corporation (NASDAQ:INTC)NASDAQ:AMKRNASDAQ:INTCNASDAQ:NVDANVIDIA Corporation (NASDAQ:NVDA)NYSE:DELLNYSE:ORCLOracle Corporation (NYSE:ORCL)Yahoo Finance
Share6Tweet4

Global Market Bulletin

Global Market Bulletin is a leading provider of stock market updates, economic news, and personalized investing guides. Our team brings you the latest global financial information to help you make smart investment decisions. About the Editorial Team Our editorial team consists of financial experts and seasoned market analysts who bring decades of experience to our coverage. With a commitment to unbiased reporting, our team ensures that every article is backed by thorough research and delivers accurate financial insights.

Recommended For You

10 Stocks With Billion-Dollar Potential You Should Not Miss

by Global Market Bulletin
July 25, 2026
0
10 Stocks With Billion-Dollar Potential You Should Not Miss

In this article, we will take a look at the 10 Stocks With Billion-Dollar Potential You Should Not Miss. Wall Street ended the week caught between optimism and...

Read moreDetails

Could ARS Pharmaceuticals (SPRY) Disrupt the Emergency Allergy Treatment Market?

by Global Market Bulletin
July 18, 2026
0
Could ARS Pharmaceuticals (SPRY) Disrupt the Emergency Allergy Treatment Market?

We recently published our article 5 Stocks Under $10 Analysts Believe Could Soar 200%. To read the full story, you can go directly to 10 Stocks Under $10...

Read moreDetails

Is Lexeo Therapeutics (LXEO) a Good Gene Therapy Stock for Long-Term Growth?

by Global Market Bulletin
July 18, 2026
0
Is Lexeo Therapeutics (LXEO) a Good Gene Therapy Stock for Long-Term Growth?

We recently published our article 5 Stocks Under $10 Analysts Believe Could Soar 200%. To read the full story, you can go directly to 10 Stocks Under $10...

Read moreDetails

Is Sagimet Biosciences (SGMT) a Promising Biotech Stock to Buy Before Its Next Catalyst?

by Global Market Bulletin
July 18, 2026
0
Is Sagimet Biosciences (SGMT) a Promising Biotech Stock to Buy Before Its Next Catalyst?

We recently published our article 5 Stocks Under $10 Analysts Believe Could Soar 200%. To read the full story, you can go directly to 10 Stocks Under $10...

Read moreDetails

What Makes SharpLink (SBET) a High-Risk Stock Investors Cannot Ignore?

by Global Market Bulletin
July 18, 2026
0
What Makes SharpLink (SBET) a High-Risk Stock Investors Cannot Ignore?

We recently published our article 5 Stocks Under $10 Analysts Believe Could Soar 200%. To read the full story, you can go directly to 10 Stocks Under $10...

Read moreDetails

Browse by Category

  • CEO Interviews
  • Economy
  • Investing
  • Stock Market News
  • Uncategorized

QUICK LINKS

  • Stock Market News
  • Investing
  • Economy
  • Contact Us
  • About Global Market Bulletin
  • Editorial Policy – Global Market Bulletin
  • Our Editorial Team

RECENT POSTS

  • 5 Stocks With Billion-Dollar Potential You Should Not Miss
  • 10 Stocks With Billion-Dollar Potential You Should Not Miss
  • Could ARS Pharmaceuticals (SPRY) Disrupt the Emergency Allergy Treatment Market?

GET EMAIL MARKET UPDATES

Subscribe to our mailing list to receives daily updates direct to your inbox!
  • Privacy Policy
  • Terms and Conditions

© 2022 Global Market Bulletin. All Rights Reserved.

No Result
View All Result
  • Home
  • Stock Market News
  • Investing
  • Economy

© 2022 Global Market Bulletin. All Rights Reserved.

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?